NASDAQ:MTCR
Metacrine, Inc.
- Stock
Market Cap
25.48M
Beta: −0.74
PE Ratio
−0.98
PFCF: −1.05
Dividend Yield
99.76%
Payout:0%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|
average inventory | 909.50K - | ||||
average payables | 721K - | 286.50K 60.26% | 351K 22.51% | ||
average receivables | 13K - | ||||
book value per share | -2.70 - | -4.07 50.76% | 9.49 333.24% | 1.36 85.65% | |
capex per share | -0.04 - | -0.00 87.93% | -0.02 401.26% | -0.00 99.13% | |
capex to depreciation | -0.83 - | -0.10 87.84% | -0.22 118.63% | -0.01 96.28% | |
capex to operating cash flow | 0.03 - | 0.00 88.82% | 0.01 87.92% | 0.00 97.02% | |
capex to revenue | -0.48 - | ||||
cash per share | 3.83 - | 2.90 24.38% | 17.86 516.88% | 2.47 86.18% | |
days of inventory on hand | |||||
days payables outstanding | |||||
days sales outstanding | |||||
debt to assets | 0.19 - | 0.10 48.91% | 0.18 82.05% | ||
debt to equity | -0.15 - | 0.11 177.42% | 0.25 117.46% | ||
dividend yield | |||||
earnings yield | -0.12 - | -0.12 7.01% | -0.49 294.86% | -2.15 342.65% | |
enterprise value | 211.06M - | 221.83M 5.10% | -12.89M 105.81% | -34.73M 169.53% | |
enterprise value over ebitda | -8.45 - | -7.99 5.37% | 0.35 104.39% | 0.57 61.91% | |
ev to operating cash flow | -8.28 - | -7.99 3.49% | 0.36 104.45% | 0.74 106.95% | |
ev to sales | 145.56 - | ||||
free cash flow per share | -1.37 - | -1.45 5.47% | -3.87 167.44% | -1.12 71.07% | |
free cash flow yield | -0.12 - | -0.12 5.47% | -0.49 300.15% | -1.66 237.23% | |
graham net net | -2.95 - | -4.31 46.01% | 16.27 477.39% | 1.95 88.00% | |
graham number | 9.07 - | 11.52 27.01% | 28.59 148.11% | 6.67 76.66% | |
income quality | 0.99 - | 0.96 2.82% | 0.97 1.22% | 0.76 21.90% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -86.47 - | -36.25 58.07% | -50.81 40.16% | ||
interest debt per share | 0.61 - | 1.18 92.80% | 0.36 69.23% | ||
inventory turnover | |||||
invested capital | -0.15 - | 0.11 177.42% | 0.25 117.46% | ||
market cap | 224.17M - | 226.05M 0.84% | 73.92M 67.30% | 28.39M 61.59% | |
net current asset value | -55.15M - | -81.17M 47.19% | 87.07M 207.26% | 56.11M 35.56% | |
net debt to ebitda | 0.52 - | 0.15 71.01% | 2.37 1,455.73% | 1.03 56.32% | |
net income per share | -1.35 - | -1.45 7.01% | -3.83 163.91% | -1.45 62.03% | |
operating cash flow per share | -1.34 - | -1.44 7.99% | -3.85 166.74% | -1.12 70.91% | |
payables turnover | |||||
receivables turnover | |||||
research and ddevelopement to revenue | 15.82 - | ||||
return on tangible assets | -0.33 - | -0.46 39.27% | -0.35 25.33% | -0.76 121.54% | |
revenue per share | 0.08 - | ||||
roe | 0.50 - | 0.36 29.02% | -0.40 213.15% | -1.07 164.64% | |
roic | 0.55 - | 0.45 18.46% | -0.35 178.03% | -0.83 136.80% | |
sales general and administrative to revenue | 3.62 - | ||||
shareholders equity per share | -2.70 - | -4.07 50.76% | 9.49 333.24% | 1.36 85.65% | |
stock based compensation to revenue | 0.73 - | ||||
tangible asset value | -51.47M - | -78.24M 52.02% | 89.28M 214.11% | 57.35M 35.76% | |
tangible book value per share | -2.70 - | -4.07 50.76% | 9.49 333.24% | 1.36 85.65% | |
working capital | 69.87M - | 43.33M 37.98% | 98.00M 126.16% | 70.98M 27.57% |
All numbers in USD (except ratios and percentages)